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@yahoo.Abstract Objectives: Histological evaluation of the fate of implanted ossicular homografts in
adult New Zealand white rabbits after inactivation/preservation procedure.
Design: The study was conducted on 10 pathogen free adult NZ white rabbits at the animal lab-
oratory of Alexandria University Hospitals. Under general and local inﬁltrative anesthesia middle
ear ossicles (incus and malleus) were collected bilaterally from another ﬁve rabbits. These ossicles
underwent inactivation/preservation procedure using sodium hydroxide followed by autoclaving
at 134 C for 8 min and kept in a sterile autoclavable package. The treated ossicles were randomly
implanted in the middle ear cavity of recipient rabbits. After one month, both the homograft and
the ossicle of the same rabbit were retrieved and histologically examined.
Results: All the harvested control ossicles from the same ear showed the regular histological
structure of the compact bone. All harvested specimens of inactivated/preserved ossicular homograftEar, Nose, Throat and Allied
evier B.V. All rights reserved.
yptian Society of Ear, Nose,
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20 A.A. Omran et al.maintained their shape, contour, size and physical integrity and were surrounded by a variable layer
of ﬁbro-vascular tissue. There was bone proliferative activity with new bone formation at the periph-
ery underneath the periosteum and remodeling was evident around the bone marrow spaces. All har-
vested ossicular homografts did not show any granulomatous foreign body reaction.
Conclusion: Inactivated/preserved ossicular homograft can be considered for partial ossicular
reconstruction in some selected indications for patients lacking suitable autograft ossicles.
ª 2012 Egyptian Society of Ear, Nose, Throat and Allied Sciences.
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Allotransplantation is the transplantation of cells, tissues, or
organs, sourced from a genetically non-identical member of
the same species as the recipient. This transplant is known as
an allograft or homograft. Most human tissue and organ
transplants are allografts. A transplanted organ or tissue from
a genetically identical donor, i.e., an identical twin, is termed
an isograft. Finally, when a tissue is transplanted from one site
to another on the same patient, it is termed an autograft.1
The use of homografts is one of the standard procedures for
replacing diseased ossicles in middle ear reconstruction,2 and is
still ranked second in the United States for use in middle ear
reconstruction.3 On the other hand, the general discussion on
human immunodeﬁciency virus (HIV) and prion-associated
Creutzfeldt-Jakob disease (CJD) transmission has led to an
almost complete ban on the use of homograft ossicles in many
countries. Insufﬁciently inactivated living transplant or dead
implant material involves a risk of viral, bacterial, and/or
prion disease transmission from donor to recipient. This has
been conﬁrmed by bone-associated but not by ossicle allo-
graft-associated HIV, hepatitis, and tuberculosis transmission,
according to the literature.4
Therefore it is necessary to treat homograft ossicles with a
safe and effective method to inactivate infectious agents and
maintain proper preservation. New sterilizing or inactivating
procedures inactivate the more resilient germs, such as the
nucleotide-free putative infectious prions causing CJD, 5,6 are
recommended in the literature.
2. Aim
The aim of this work is histological evaluation of the fate of
implanted ossicular homografts in adult New Zealand white
rabbits after inactivation/preservation procedure.3. Material and methods
Ten pathogen free adult New Zealand white rabbits
(12–16 weeks old) and (weighing 1.5–2.5 kg) were used for this
study (recipient rabbits). The middle ear ossicles of another ﬁve
donor rabbits were harvested bilaterally and used as homo-
graft. The rabbits were fed regularly on a standard rabbit diet
and were kept under supervision of a veterinary doctor. The
study was carried out in the animal house and the department
of histology of Alexandria Medical School. The study was
approved by the medical ethics committee of Alexandria Fac-
ulty of Medicine.
The procedures were as follows.3.1. The anesthetic procedure
The rabbit was anesthetized generally by intramuscular injec-
tion of Ketamine 35 mg/kg + Xylazine 5 mg/kg.7 After about
5–10 min of intramuscular injection of anesthesia, the rabbit
became anesthetized. This combination gave an adequate
surgical anesthesia for about 30–60 min. After this period, usu-
ally the rabbit starts to blink denoting an early recovery sign
from the ﬁrst anesthetic dose so half of the initial dose was
given to maintain anesthesia till the end of the procedure. Sup-
plemental local inﬁltration anesthesia with Xylocaine 2% was
administrated to ensure adequate anesthesia.
3.2. The surgical procedure
The external auditory canal was cleaned from debris and wax
using suction-irrigation with normal saline. The retroauricular
area was shaved and sterilized with povidine iodine (Betadine)
followed by ethyl alcohol 70%. Under operating microscope
(Zeiss OPMI-1 lab), a post-auricular incision, approximately
2 cm long just behind post-auricular sulcus, was performed
through the skin and subcutaneous tissue using a no. 15 blade
scalpel. These soft tissues were dissected to reach and ade-
quately expose the posterior canal wall. A House sickle knife
was used to incise the posterior canal wall. The tympano-mea-
tal ﬂap was elevated carefully to reach the middle ear. Under
sufﬁcient magniﬁcation and good exposure of the ossicular
chain the incus and malleus were freed and gently transferred
to saline 0.9% solution before performing the inactivation/
preservation procedure. After this step the animal (donor)
was euthanized.
3.3. The inactivation/preservation procedure
The ossicles were immersed in 1N (normal) NaOH for 1 h fol-
lowed by autoclaving at 134 C for 8 min in a sterile autoclav-
able package and became ready to use.8
3.4. Implantation of the treated homograft
Following the same surgical procedure and after exploration of
the middle ear of the recipient rabbit, the inactivated/preserved
ossicular graft (incus or malleus) was placed (implanted) inside
the middle ear cavity over the promontory without interrup-
tion of the host ossicular chain. The tympano-meatal ﬂap
repositioned and the external canal was packed with Gelfoam.
The retroauricular incision closed with interrupted catgut su-
tures. The animal was homed, got postoperative care of the
skin incision, and local antibiotic ear drops were instilled to
avoid middle ear infection.
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One month later, the animal was euthanized and the implanted
ossicular homograft was retrieved for histological analysis.
The ossicles of the same ear were taken as a control for histo-
logical analysis as well. The retrieved ossicles (homograft and
control) were transferred to refrigerated 4F:1G solution (4%
Paraformaldehyde: 1% Glutaraldehyde in 0.1 M Phosphate
Buffer) for histological preparation.
3.6. Histological study
The specimens kept immersed in 4F:1G for 3 or 4 days and
then decalciﬁed with 10% EDTA (pH 7.4). Specimens were
decalciﬁed in this solution over 3 weeks and put in a refrigera-
tor at 4 C. The fresh solution was changed several times every
week. The specimens were embedded in parafﬁn wax, cut into
sections 6 lm thick and stained with Toluidine Blue stain. All
specimens were examined under microscopic magniﬁcation
·400 and ·1000.
4. Results
Complete wound healing occurred within the ﬁrst 7–10 days.
All animals – except two – survived until they were euthanized
about 4 weeks after implantation. No sign of active inﬂamma-
tory process or the presence of granulation tissues was
observed during retrieval of the implanted homograft in any
animal.
4.1. Histopathological ﬁndings
All the harvested control ossicles from the same ear were cov-
ered by a good layer of mucosal covering. They showed the
regular histological structure of the compact bone: Haversian
concentric bone lamellae with dispersed osteocytes surround-
ing the Haversian canals and a periosteal layer all aroundFigure 1 A control ear ossicle (incus) showing normal histolog-
ical structure of the compact bone; with multiple osteocytes within
the Haversian bone lamellae. Note: minimal remodeling activities
around bone marrow spaces (*inset), but not underneath the
periosteum lining the ossicle (arrow). (Toluidine Blue stain –
microscopic magniﬁcation ·400, ·1000 inset).the circumference of the ossicle. Bone marrow spaces appeared
as small cavities within the ossicular bony tissue (Fig. 1). All
harvested specimens of inactivated/preserved ossicular homo-
graft maintained their shape, contour, size and physical integ-
rity and were surrounded by a variable layer of ﬁbro-vascular
tissue. A considerable ﬁnding was the presence of bone prolif-
erative activity with the formation of new bone by osteoblasts
at the periphery underneath the periosteum (Figs. 2 and 3). On
the other hand, remodeling was evident around the bone mar-
row spaces in the form of bone resorption and bone deposition
(Figs. 2 and 4). All harvested specimens of inactivated/pre-
served ossicular homografts did not show any granulomatous
foreign body reaction.
5. Discussion
Otologic homografts have been used for replacement of tym-
panic membranes, replacement of ossicles, closure of the oval
window, and canalplasty since the early 1960s. Preservation
of homografts, usually obtained from cadavers, and sometimes
during ossicular surgery on living patients, has been a point of
contention from the outset.
In the literature, there are various reports concerning pres-
ervation of Otologic grafting materials and mainly dominatedFigure 2 A treated homograft ear ossicle showing comparable
histological structure to the control bone; but with marked osteo-
proliferative activity both around bone marrow spaces (white
arrow) and within the periosteum layer (black arrow). (Toluidine
Blue stain – microscopic magniﬁcation ·400).
Figure 3 A higher magniﬁcation of the treated ossicle showing
numerous proliferating osteoblasts (arrows) and new bone for-
mation underneath the periosteum. (Toluidine Blue stain –
microscopic magniﬁcation ·1000).
Figure 4 A higher magniﬁcation of the treated ossicle showing
the marked remodeling activities around the bone marrow spaces;
bone resorption by osteoclasts (black arrow) and new bone
deposition by proliferating osteoblasts (white arrow). (Toluidine
Blue stain – microscopic magniﬁcation ·1000).
22 A.A. Omran et al.by cialit, introduced for Otologic use by Marquet9, isopropyl
alcohol, introduced by House et al.,10 formaldehyde intro-
duced by Perkins.11
Many questions were raised about the ossicular homografts
in literature, all about its role in transmission of certain dis-
eases as HIV, prion diseases as Creutzfeldt-Jakob disease
(CJD) or even cholesteatoma. But many studies and articles
were defending the homografted ossicles with scientiﬁc evi-
dences. 12 Cura et al. conﬁrmed the possibility and safety of
using homogarft incus or malleus from appropriate donors
without risk of prion transmission. This was done by ossicle
autoclaving at 135 C temperature for 20 min after immersing
the ossicles in 4% formol solution at pH 5.6 for 3 days, and
then the ossicle was kept refrigerated at 4 C in 0.5% formol
solution at pH 7. This procedure destroys all the cellular ele-
ments in ossicles, preserving the bone matrix and thus provid-
ing the surgeon with the advantages of using ossicles
uncontaminated with cholesteatomas or prions.13 In the same
decade, a new NaOH-autoclaving inactivation/preservation
procedure (IPP) for ossicle homografts, complying with the ac-
tual infectious disease guidelines, has been developed and used
in Berne (Switzerland) by Romualdez et al.8
In this study, we observed that complete wound healing
occurred within the ﬁrst 10 days. Histopathologically, we
examined every specimen for the degree of inﬂammation,
foreign body reaction, ﬁbrous tissue formation, and any evi-dence of new bone formation. Histopathologic study of control
ossicles from the same ear showed the regular histological
structure of the compact bone: Haversian concentric bone
lamellae with dispersed osteocytes surrounding the Haversian
canals and a periosteal layer all around the circumference of
the ossicle. Bone marrow spaces appeared as small cavities
within the ossicular bony tissue. Histopathologic study of inac-
tivated/preserved ossicular homograft by the method of inacti-
vation/preservation showed that all harvested specimens of
inactivated/preserved ossicular homograft maintained their
shape, contour, size and physical integrity after at least 4 weeks
of implantation.
All specimens of inactivated/preserved ossicular homograft
and control ossicles showed minimal to mild inﬂammatory
reaction without any granulomatous foreign body reaction.
This inﬂammatory reaction was correlated with a resolving
acute inﬂammatory reaction that follows the surgical proce-
dures. A variable layer of ﬁbro-vascular tissue was surround-
ing the implanted ossicular homograft; in comparison of a
good layer of mucosa covering the control ossicles.
All specimens of inactivated/preserved ossicular homograft
showed bone proliferative activity with too many areas of new
bone formation evidenced by presence of many osteoblasts at
the periphery underneath the periosteum and also in the core
of the implanted ossicles surrounding revascularized Haversian
canals.
On the other hand, remodeling activity was evident around
the bone marrow spaces in the form of bone resorption and
bone deposition in a phenomenon named creeping substitution
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implanted ossicular homograft. Creeping substitution is an
old terminology concerning the process of bone remodeling
by osteoclastic resorption and creation of new vascular chan-
nels with osteoblastic bone formation.14
Histopathologic changes observed in our study were similar
to previous studies that investigated the human ossicular
homografts; whether using the same preservative (NAOH) or
other preservatives such as cialit–formaldehyde.
Romualdez et al. compared the clinical, anatomical and
audiological results of middle ear reconstruction using the
new NaOH-autoclaving inactivated ossicle homografts (22
patients) and the previously used cialit–formaldehyde inactiva-
tion procedure (28 patients). During the follow-up period, no
sign for homograft extrusion, resorption or disease transmis-
sion were observed either for the NaOH-autoclaving or for
the cialit–formaldehyde protocol. Histological analysis of 2
patients incuses, removed during revision surgery 6 and
10 months after implantation treated by either NaOH or cialit,
revealed a well preservative conﬁguration of the homograft
with anatomically intact mucoperiosteum and inner bone
spaces invaded by blood vessels, ﬁbrous tissue and osteocytes.
8
Merchant and Nadol studied the fate of 10 autograft and a
single homograft (incus and malleus) removed from ears
revised after 5 months to 11 years. The ossicles maintained
their contour, size, shape, and physical integrity for at least
up to 11 years. No sign of foreign body reaction was observed
in any specimen even in the homograft ossicle. They noticed
that autografts became non-vital after implantation, because
of loss of blood supply, which is characterized histologically
by drop-out of osteocytes and empty Haversian canals devoid
of blood vessels. New bone formation and remodeling by a
slow process of creeping substitution was evident in all grafts
(both types), the rate of which depended on revascularization
of the graft and not on duration of implantation.15
It was reported also that non-vital grafts appear to main-
tain their morphologic structure and integrity and, therefore,
transmit sound just as well as their living counterparts. In this
respect, they differ from bone grafts in orthopedic surgery, in
which weight-bearing stresses make non-vital grafts prone to
fatigue fractures.16 Middle ear grafts (both non-vital and via-
ble), however, are subject to resorption by rarefying osteitis
when there is recurrent middle ear suppuration, similar to that
observed in ossicles in chronic otitis media. Investigators have
shown that histologic changes in homograft human ossicles are
similar to those in autografts, except that creeping substitution
occurs less rapidly in homografts.15,17.
Autogenous malleus, incus and cortical bone grafts, and
homograft ossicles behave similarly and maintain their mor-
phologic size, shape, and contour for long periods. They nei-
ther incite formation of new bone nor undergo resorption.
They show varying process of creeping substitution that is
dependent on revascularization and not on duration of
implantation. These histologic observations support the con-
tinued use of bone grafts for ossicular reconstruction. Drilling
and modifying the shape (sculpturing) of such grafts should be
done with adequate irrigation to avoid thermal injury of the
bone cells and subsequent bone necrosis.156. Conclusions
Using the newly NAOH-autoclaving inactivation/preservation
procedure achieves functional and structural results that made
it a safe, simple and effective method of inactivation/preserva-
tion of the ossicular homograft.
Finally we conclude that if available, the autogenous ossicle
represents the gold standard as material for the partial ossicu-
lar reconstruction. If not, inactivated/preserved ossicular
homograft can be considered in some selected indications for
patients lacking suitable autograft ossicles.
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